Invesaro

Stocks SIRI Financial statements

Financial statements

SIRIUS XM HOLDINGS INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SIRIUS XM HOLDINGS INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue5,0175,4255,7717,7948,0408,6969,0038,9538,6998,558
Cost of revenue40.935.43,383
Gross profit4,9765,3904,4114,5054,7734,9194,7894,6164,488
Research and development82.1112123280263265285322296263
Selling and marketing3874384849379571,0561,075931894760
General and administrative341335354524511514563608497549
Operating income1,4321,6411,7271,6478582,0151,9191,808-1,5171,471
Interest expense331346350390394415422423496459
Other non-operating income-340-377-306-450-428-489-433-598-348-415
Pre-tax income1,0921,2641,4211,1974301,5261,4861,210-1,8651,056
Income tax346616245283299212368222210251
Net income to minority interests210202-4100
Net income7466481,1769141311,314908786-1,665805
EBITDA1,6531,9022,0051,9741,2122,3942,3182,233-1,0721,893
EPS, basic1.431.342.481.910.293.063.222.91-6.142.38
EPS, diluted1.431.342.481.910.293.062.962.77-6.142.23
Shares, basic (weighted)515486467471453425347339338338
Shares, diluted (weighted)520495478483464434368362338357
Dividend per share0.100.390.430.470.520.630.340.10

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents21469541067119136230616294
Receivables97.190.898532559626574616596671
Inventory20.420.2221110
Other current assets179130158194204246284310290218
Total current assets6434714781,0039671,1801,0381,3611,1491,098
Property, plant and equipment1,3991,4631,5131,6261,6291,4501,4991,7912,1092,260
Lease right-of-use assets0466427358315279277223
Goodwill2,2052,2872,2903,8433,1223,15115,20915,20912,39012,390
Intangible assets2,5452,5232,5013,4673,3403,1863,05010,31010,18910,065
Other non-current assets119119138139206223236670641483
Total assets8,0048,3298,17311,14910,33310,27410,02230,05627,52127,237
Deferred revenue1,8331,8821,9321,9301,7211,4541,3221,1951,050976
Short-term debt5.495.1132101961,079611,058
Total current liabilities2,6692,8222,8033,2933,1672,9802,9813,9512,7313,653
Long-term debt5,8436,7416,8857,8428,4998,8329,25610,07310,3148,648
Lease liabilities0456419362320292291229
Other non-current liabilities93.6100102941491501704281,1001,043
Total liabilities8,7969,8539,99011,88512,61812,89913,37316,95416,44715,674
Total debt5,8486,7466,8887,8448,5008,8329,45211,15210,3759,706
Paid-in capital3,1181,71424239500000
Retained earnings-3,891-3,243-2,057-1,143-2,285-2,636-3,35115,35311,12111,614
Treasury stock-22.9-17.200-19-800-1-1
Other comprehensive income-0.1418.4-681515-47-46-50
Shareholders' equity-792-1,522-1,817-736-2,285-2,625-3,35110,07611,07411,563
Minority interests3,0260
Total equity-792-1,522-1,817-736-2,28513,13412,37113,10211,07411,563
Total liabilities and equity8,0048,3298,17311,14910,33310,27410,02230,05627,52127,237
Shares outstanding4974744554624374153,8910339335

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income7466481,1769141311,3141,118988-2,075805
Depreciation and amortization220261278327354379399425445422
Stock-based compensation109124133250223202209203200179
Deferred income tax324584257259238131240-40-16129
Change in receivables-44.2-74-42-137-36-10810-114
Change in inventory1.932-211-2
Change in payables78.941-2010942104-7162
Cash from operations1,7191,8561,8802,0172,0181,9981,9811,8291,7411,898
Capital expenditures-206-288-355-363-350-388-426-650-728-653
Acquisitions0-108-2313-300-14-13600
Purchases of investments0-612
Sales and maturities of investments6600
Cash from investing-210-1,147-379-3-741-200-493-696-970-747
Debt issued9872,47302,7151,4814,4426001,0111,1000
Debt repaid-661-1,513-16-1,666-1,507-3,503-419-2,032-1,809-699
Stock issued0.3510801044
Share buybacks-1,674-1,409-1,314-2,159-1,555-1,523-647-274-6-136
Dividends paid-48.1-190-201-226-237-268-249-65-143-365
Cash from financing-1,407-854-1,515-1,959-1,314-1,682-1,724-1,188-916-1,219
Net change in cash102-145-1455-37116-236-55-145-68
Free cash flow1,5131,5681,5251,6541,6681,6101,5551,1791,0131,245
Interest paid293310345337358393487507473439
Income taxes paid20.6286103882136165218156

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $25.86 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin52.8%Gross profit / revenue.
Operating margin19.1%Operating income / revenue.
EBITDA margin24.6%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin13.5%Pre-tax income / revenue.
Net margin10.2%Net income / revenue.
FCF margin18.0%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin24.4%Cash from operations / revenue.
Effective tax rate24.2%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)7.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)3.2%Net income / average total assets.
Return on invested capital (ROIC)5.9%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue3.0%Research and development expense / revenue.
Stock-based pay / revenue2.1%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue6.4%Capital expenditures / revenue.
D&A / revenue5.5%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y-1.6%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y-1.7%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y1.3%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y-2.8%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y-3.0%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y-0.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income CAGR, 3y-8.5%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y11.4%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA CAGR, 3y-6.5%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y9.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income CAGR, 3y-3.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y43.8%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS CAGR, 3y-9.0%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y50.7%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y9.0%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-1.4%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-1.2%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y22.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-7.1%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-5.7%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y4.4%Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y-1.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y39.6%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y21.4%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y5.6%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-5.1%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.46xCurrent assets / current liabilities.
Quick ratio0.32x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.07x(Cash + short-term investments) / current liabilities.
Debt / equity0.79xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets34.8%Total debt / total assets.
Liabilities / assets56.2%Total liabilities / total assets.
Net debt$9.28BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA4.38xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage3.66xOperating income / interest expense.
Working capital-$1.37BCurrent assets - current liabilities.
Goodwill and intangibles / assets82.4%(Goodwill + intangible assets) / total assets.
Tangible book value-$10.49BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.32xRevenue / average total assets.
Fixed asset turnover3.76xRevenue / average property, plant and equipment.
Receivables turnover13.7xRevenue / average receivables.
Days sales outstanding27 days365 x average receivables / revenue.
FCF conversion176.0%Free cash flow / net income, when net income is positive.
Capex / operating cash flow26.3%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.57Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$25.16Revenue / diluted weighted shares.
FCF per share$4.53Free cash flow / diluted weighted shares.
Operating cash flow per share$6.15Cash from operations / diluted weighted shares.
Book value per share$35.34Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$31.11Tangible book value / shares outstanding.
Cash per share$0.52(Cash + short-term investments) / shares outstanding.
Payout ratio41.4%Dividends paid / net income, when net income is positive.
Dividends / FCF23.5%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF6.1%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$8.71BShare price x shares outstanding.
Enterprise value$18.00BMarket cap + total debt - cash - short-term investments.
P/E9.90xMarket cap / net income. Only when net income is positive.
P/S1.01xMarket cap / revenue.
P/B0.73xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF5.63xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF4.14xMarket cap / cash from operations, when positive.
EV/Sales2.09xEnterprise value / revenue.
EV/EBIT10.9xEnterprise value / operating income, when both are positive.
EV/EBITDA8.50xEnterprise value / EBITDA, when both are positive.
EV/FCF11.6xEnterprise value / free cash flow, when both are positive.
FCF yield17.8%Free cash flow / market cap.
Earnings yield10.1%Net income / market cap (the inverse of P/E).
Dividend yield4.2%Dividends paid over the period / market cap.
Shareholder yield5.3%(Dividends paid + share buybacks) / market cap.
What was SIRIUS XM HOLDINGS INC.'s revenue in fiscal 2025?

SIRIUS XM HOLDINGS INC. reported revenue of $8.56B for fiscal 2025, 1.6% lower than the year before.

Was SIRIUS XM HOLDINGS INC. profitable in fiscal 2025?

Yes. Net income was $805.0M, a net margin of 9.4%.

How much free cash flow did SIRIUS XM HOLDINGS INC. generate in fiscal 2025?

Cash from operations of $1.90B minus capital expenditures of $653.0M left free cash flow of $1.25B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SIRIUS XM HOLDINGS INC.